Gd-IgA1

Harbour BioMed’s WIN378 Shows Positive Phase 2 Asthma Data

Cambridge, Massachusetts, U.S.; Rotterdam, Netherlands; and Shanghai, China, September 8, 2026 Harbour BioMed has announced positive interim results from...

By cGxPwire Editor
September 9, 2026

Pharma

Alebund’s AP308 Gets FDA IND Clearance for IgA Nephropathy

Shanghai, China, September 8, 2026 Alebund Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has cleared...

By cGxPwire Editor
September 9, 2026

.Clinical

Climb Bio Phase 1 Data Support CLYM116 Q12W Dosing in IgA Nephropathy

Wellesley Hills, Mass., September 3, 2026 Climb Bio announced positive initial Phase 1 clinical data for CLYM116, its investigational...

By cGxPwire Editor
September 4, 2026

Pharma

Alkem Launches India’s First Semaglutide Pre-Filled Syringe

MUMBAI, India, June 2, 2026 Alkem Laboratories has announced the launch of India’s first semaglutide single-shot pre-filled syringes, marking...

By cGxPwire Editor
June 6, 2026

.Clinical

Otsuka’s VOYXACT Preserves Kidney Function in Phase 3 IgAN Trial

GLASGOW, Scotland, June 4, 2026 Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Development & Commercialization, Inc. have announced positive...